Taiwan FDA registration 25c03aaa6fa56fb240cd2df97b5f2a26
“HippoScreen” Stress EEG Assessment System
TW: “宏智生醫”憂可視腦波壓力評估系統
Registration details
- Analysis ID
- 25c03aaa6fa56fb240cd2df97b5f2a26
- License Form
- Ministry of Health Medical Device Manufacturing No. 008104
Company information
- Manufacturer
- Hongzhi Biomedical Technology Co., Ltd
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- Hongzhi Biomedical Technology Co., Ltd
Product details
- Intended Use
- The software medical device (SaMD) to assist in the diagnosis of suspected depression is used to analyze the time-domain and frequency-domain characteristics of the brainwave data measured by the brainwave smograph, and generate a quantitative index (SEA Index), which is provided to medical professionals as a diagnostic reference. This system is only used by medical professionals as a reference for clinical assistance in diagnosing suspected depression, and cannot replace the judgment of medical professionals.
- Product Type (Level 1)
- K Neuroscience
- Product Type (Level 2)
- K1400 brainwave scanner
- Import Information
- Produced in Taiwan, China
Dates and status
- Registration Date
- Oct 13, 2023
- Expiry Date
- Oct 13, 2028
About this record
Access comprehensive regulatory information for “HippoScreen” Stress EEG Assessment System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 25c03aaa6fa56fb240cd2df97b5f2a26 and manufactured by Hongzhi Biomedical Technology Co., Ltd. The authorized representative in Taiwan is Hongzhi Biomedical Technology Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices